Case number 1:25-cv-00318
Otsuka Pharmaceutical Co., Ltd. v. Alkem Laboratories Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2025 | N/A | SO ORDERED, re 10 STIPULATION for Extension of Time (*Reset Answer Deadlines: Alkem Laboratories Ltd. answer due 7/28/2025). Signed by Judge Richard G. Andrews on 6/27/2025. (nms) (Entered: 06/27/2025) (0) |
| Jun 26, 2025 | 10 | STIPULATION for Extension of Time - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth) Modified on 6/27/2025 (nms). (Entered: 06/26/2025) (1) |
| Jun 18, 2025 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Aaron M. Johnson and Attorney Jaimin H. Shah - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth) (Entered: 06/18/2025) (4) |
| Jun 18, 2025 | 9 | Pro Hac Vice Fee - Credit Card Payment received for Stephen R. Auten, Aaron M. Johnson, and Jaimin H. Shah. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Aaron M. Johnson and Attorney Jaimin H. Shah )( Payment of $ 150, receipt number ADEDC-4714325).(Dorsney, Kenneth) (Entered: 06/18/2025) (0) |
| Jun 18, 2025 | N/A | SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Attorney Aaron M. Johnson and Attorney Jaimin H. Shah filed by Alkem Laboratories Ltd.. Signed by Judge Richard G. Andrews on 6/18/2025. (aas) (Entered: 06/18/2025) (0) |
| Apr 1, 2025 | 7 | WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For Alkem Laboratories Ltd. waiver sent on 3/31/2025, answer due 6/30/2025. (Tigan, Jeremy) (Entered: 04/01/2025) (1) |
| Mar 19, 2025 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 03/19/2025) (0) |
| Mar 13, 2025 | 1 | COMPLAINT for Patent Infringement against Alkem Laboratories Ltd. (Filing fee $ 405, receipt number ADEDC-4636257) - filed by Otsuka Pharmaceutical Co., Ltd. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(jfm) Modified on 3/13/2025 (nms). (Entered: 03/13/2025) (0) |
| Mar 13, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/13/2025) (3) |
| Mar 13, 2025 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/31/2025. Date of Expiration of Patent: U.S. Patent No. 8,501,730 on 09/01/2026, U.S. Patent No. 10,905,694 on 04/07/2030, & U.S. Patent No. 8,273,735 on 08/14/2028.Thirty Month Stay Deadline: 7/31/2027. (jfm) (Entered: 03/13/2025) (1) |
| Mar 13, 2025 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2; 10,905,694 B2; 8,273,735 B2. (jfm) (Entered: 03/13/2025) (1) |
| Mar 13, 2025 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. - filed by Otsuka Pharmaceutical Co., Ltd. (jfm) (Entered: 03/13/2025) (1) |
| Mar 13, 2025 | 6 | Summons Issued as to Alkem Laboratories Ltd. on 3/13/2025. (jfm) (Entered: 03/13/2025) (2) |
